These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 2899510)

  • 1. Beta-blockade antagonism of tyramine-induced rise in blood pressure.
    Colombo F; Sega R; Mailland F; Rigo R; Palvarini L; Libretti A
    Eur J Clin Pharmacol; 1988; 34(3):263-6. PubMed ID: 2899510
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dose-response studies of indenolol, a beta adrenoceptor blocker.
    Okupa FE; Daneshmend TK; Shrosbree E; Roberts CJ
    Clin Pharmacol Ther; 1981 Apr; 29(4):434-9. PubMed ID: 6110504
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Acute effect of indenolol on systemic arterial pressure and heart rate in the rat.
    Zuccari G; Falcone A; Turba C
    Pharmacol Res Commun; 1986 Feb; 18(2):137-47. PubMed ID: 2871567
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Renal and limb vasodilatation during acute beta-adrenoceptor blockade with indenolol.
    Poggesi L; Bisi G; La Cava G; Sciagra R; Del Rosso A; Masotti G
    J Clin Pharmacol; 1995 Feb; 35(2):176-81. PubMed ID: 7751429
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acute effect of indenolol on human airways.
    Zanon P; Bruschi C; Cerveri I; Rossi A; Karitinos P; Pamparana F
    Eur J Clin Pharmacol; 1985; 29(3):287-92. PubMed ID: 2866966
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Indenolol, a beta-blocker with partial agonism at vascular beta-adrenoceptors.
    Taddei S; Pedrinelli R; Salvetti A
    Clin Pharmacol Ther; 1989 Nov; 46(5):560-5. PubMed ID: 2573443
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of prolonged administration of indenolol in hypertensive rats.
    Kato H; Kurihara J; Takata Y; Kunugi H; Miyajima Y
    Arch Int Pharmacodyn Ther; 1983 Jul; 264(1):82-95. PubMed ID: 6138007
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of selective beta 2-adrenoceptor blockade on serum potassium and exercise performance in normal men.
    Gullestad L; Birkeland K; Nordby G; Larsen S; Kjekshus J
    Br J Clin Pharmacol; 1991 Aug; 32(2):201-7. PubMed ID: 1681847
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Influence of adrenoceptor and muscarinic receptor blockade on the cardiovascular effects of exogenous noradrenaline and of endogenous noradrenaline released by infused tyramine.
    Schäfers RF; Poller U; Pönicke K; Geissler M; Daul AE; Michel MC; Brodde OE
    Naunyn Schmiedebergs Arch Pharmacol; 1997 Feb; 355(2):239-49. PubMed ID: 9050018
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vasodilating mechanism and response to physiological pressor stimuli of acute doses of carvedilol compared with labetalol, propranolol and hydralazine.
    Tomlinson B; Bompart F; Graham BR; Liu JB; Prichard BN
    Drugs; 1988; 36 Suppl 6():37-47. PubMed ID: 2908303
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of indenolol on blood pressure, lower limb blood flow, adrenergic reflexes, and plasma renin activity.
    Poggesi L; Masotti G; Boddi M; Neri Serneri GG
    Clin Pharmacol Ther; 1987 Mar; 41(3):344-50. PubMed ID: 2880689
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Haemodynamics of carvedilol in normal subjects compared with propranolol, pindolol, and labetalol.
    Tomlinson B; Cronin CJ; Graham BR; Prichard BN
    J Cardiovasc Pharmacol; 1987; 10 Suppl 11():S69-75. PubMed ID: 2454372
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Metabolic, electrocardiographic, and hemodynamic responses to increased circulating adrenaline: effects of selective and nonselective beta adrenoceptor blockade.
    Hansen O; Johansson BW; Nilsson-Ehle P
    Angiology; 1990 Mar; 41(3):175-88. PubMed ID: 1968731
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of beta-adrenergic receptor blocking agents on blood pressure in conscious hypertensive rats.
    Nakao K; Kato H; Takagi K
    Jpn J Pharmacol; 1975 Feb; 25(1):25-34. PubMed ID: 239267
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of the antifibrillatory activity of fluorinated derivatives of indenolol and nadolol in isolated rabbit and rat hearts: comparison with propranolol.
    Almotrefi AA; Aboul-Enein HY; Premkumar LS
    Arch Int Pharmacodyn Ther; 1989; 301():122-30. PubMed ID: 2576192
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An assessment of the partial agonist activity of Ro 31-1118, flusoxolol and pindolol in man.
    McCaffrey PM; Riddell JG; Shanks RG
    Br J Clin Pharmacol; 1987 Nov; 24(5):571-80. PubMed ID: 2893634
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adrenoceptor mechanisms in the cardiovascular effects of cocaine in conscious squirrel monkeys.
    Schindler CW; Tella SR; Goldberg SR
    Life Sci; 1992; 51(9):653-60. PubMed ID: 1354322
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative effects of adimolol, labetalol and propranolol on heart rate and blood pressure in man.
    Riddell JG; Harron DW; Shanks RG
    Br J Clin Pharmacol; 1985 Apr; 19(4):405-10. PubMed ID: 2859871
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical pharmacology of a new beta-adrenoceptor blocking drug, befunolol. Cross-over comparison with propranolol on repeated administration.
    Ebihara A; Tawara K; Oka T; Ofuji T; Kawahara K
    Eur J Clin Pharmacol; 1982; 23(3):189-95. PubMed ID: 6129139
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of indenolol (YB-2), a new beta-adrenergic blocking agent, and its dextro isomer on the central nervous system of mice and rabbits.
    Tachikawa S; Takenaka T; Maeno H
    Arch Int Pharmacodyn Ther; 1978 Jul; 234(1):74-87. PubMed ID: 30422
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.